Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Daily News

Thin-Cap Fibroatheromas May Help Explain Poor PCI Outcomes in Diabetic Patients

Todd Neale

July 06, 2016

News Conference News EuroPCR 2015

Evolving DES Technology May Benefit Diabetic Patients

Caitlin E. Cox

May 19, 2015

News Daily News

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

Todd Neale

November 17, 2014

Presentation TCT 2014

Impact of Pioglitazone on Cardiovascular Events in Patients with Diabetes Mellitus after Drug-eluting Stent Implantation: Evidence from 3-Year Follow-up Results of the J-DESsERT___

Presenter: Hiroyoshi Yokoi

September 16, 2014

News Daily News

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Caitlin E. Cox

March 13, 2014

News Daily News

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Yael L. Maxwell

February 26, 2014

Presentation TCT 2013

FREEDOM: A Prospective, Randomized Trial of First Generation Drug-Eluting Stents vs. CABG in Insulin- and Noninsulin-Treated Diabetic Patients

Presenter: George Dangas

October 31, 2013

News Daily News

Drug-Eluting Balloons Lower TLR in Diabetics with Critical Limb Ischemia

Jason Kahn

July 05, 2013

News Daily News

SES Show Advantage Over ZES, PES for Diabetic Patients

Yael L. Maxwell

June 20, 2013

News Daily News

Colchicine Reduces BMS Restenosis in Diabetic Patients

April 19, 2013

Presentation TCT 2013

Paclitaxel Drug Eluting Balloon Versus Standard Angioplasty To Reduce Restenosis In Diabetic Patients With In Stent Restenosis Of The Superficial Femoral And Proximal Popliteal...

Presenter: Francesco Liistro, Paolo Angioli, Guido Bellandi, Leonardo Bolognese, Kenneth Ducci, Italo Porto, Filippo Turini, Giorgio Ventoruzzo

January 31, 2013

News Daily News

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

Yael L. Maxwell

January 09, 2013

News Daily News

Studies Support DES Use in Diabetics, But Results Vary by Device

Caitlin E. Cox

March 08, 2011

Advertisement

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Thin-Cap Fibroatheromas May Help Explain Poor PCI Outcomes in Diabetic Patients

Evolving DES Technology May Benefit Diabetic Patients

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

Impact of Pioglitazone on Cardiovascular Events in Patients with Diabetes Mellitus after Drug-eluting Stent Implantation: Evidence from 3-Year Follow-up Results of the J-DESsERT___

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

FREEDOM: A Prospective, Randomized Trial of First Generation Drug-Eluting Stents vs. CABG in Insulin- and Noninsulin-Treated Diabetic Patients

Drug-Eluting Balloons Lower TLR in Diabetics with Critical Limb Ischemia

SES Show Advantage Over ZES, PES for Diabetic Patients

Colchicine Reduces BMS Restenosis in Diabetic Patients

Paclitaxel Drug Eluting Balloon Versus Standard Angioplasty To Reduce Restenosis In Diabetic Patients With In Stent Restenosis Of The Superficial Femoral And Proximal Popliteal...

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

Studies Support DES Use in Diabetics, But Results Vary by Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content